What is ExperTox?
ExperTox distinguishes itself in the field of toxicology and molecular testing by offering comprehensive services in drug and alcohol testing, toxic exposure assessments, and poison or toxin identification. Boasting over 25 years of operational experience, the company places a strong emphasis on client support, providing personalized assistance throughout the entire testing process. ExperTox's core mission is to integrate advanced scientific expertise with empathetic service delivery, ensuring that clients receive precise analytical results and the essential information needed for informed decision-making. Their offerings cater to diagnostic, clinical, and civil applications, though they are not intended for forensic analysis.
How much funding has ExperTox raised?
ExperTox has raised a total of $336K across 2 funding rounds:
Debt
$150K
Debt
$186K
Debt (2020): $150K with participation from PPP
Debt (2021): $186K led by PPP
What's next for ExperTox?
The substantial backing and recent strategic investment indicate that ExperTox is poised for a significant scaling phase. This capital infusion is likely to fuel advancements in their service offerings, potentially expanding their molecular testing capabilities and broadening their reach in drug and alcohol screening. Furthermore, the company may leverage this financing to enhance its technological infrastructure, invest in research and development for novel testing methodologies, and strengthen its market presence in toxicology services. The focus on customer care and personalized support suggests a continued commitment to client relationships as ExperTox pursues its growth objectives.
See full ExperTox company page
